Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[New era in cancer therapy. Gefitinib: small molecule--strong action].

MMW Fortschritte der Medizin - 18 Nov 2004

Arnheim Katharina

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Non-Small-Cell Lung
Share to Clinical Trials, Phase III as Topic
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gefitinib

Share to Protein Kinase Inhibitors

Share to Quinazolines

Share to Randomized Controlled Trials as Topic

Source

Identifiers

PMID: 15624666

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[New era in cancer therapy. Gefitinib: small molecule--strong action].PMID 15624666Read ↗

Gefitinib. Still no convincing results in non-small cell lung cancer.Semantic proximity Read ↗

[EGFR pathway and mechanism of action of tyrosine kinase inhibitors].Semantic proximity Read ↗

[Recent developments in targeted therapy for cancers and drug discovery].Semantic proximity Read ↗

[New therapeutic option for leukemia patients, with FLT3/Aurora kinase inhibitor, KW-2449: strategy and comparison with other kinase inhibitors].Semantic proximity Read ↗

Geftinib.Semantic proximity Read ↗

[Novel molecular targets for anticancer drugs].Semantic proximity Read ↗

A vanishing act: the incredible erlotinib.Semantic proximity Read ↗

[New targets for molecular therapy of acute leukemia: a "single-hit" or "multiple-hit" strategy against signaling pathway].Semantic proximity Read ↗

Activity of gefitinib in a non-small-cell lung cancer patient with both activating and resistance EGFR mutations.Semantic proximity Read ↗

[Methods for the preclinical screening of new anticancer agents].Semantic proximity Read ↗

Small molecules with EGFR-TK inhibitor activity.Semantic proximity Read ↗

Proposing New Potential Candidates to Inhibit EGFR via Machine Learning AlgorithmSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.